title: [Evaluation of the impact of a letter of information about metoclopramide].
authors.forename: M J
authors.initials: MJ
authors.lastname: Jean-Pastor
authors.forename: F
authors.initials: F
authors.lastname: Rodor
authors.forename: N
authors.initials: N
authors.lastname: Nguyen
authors.forename: D
authors.initials: D
authors.lastname: Gambini
authors.forename: C
authors.initials: C
authors.lastname: Locatelli
authors.forename: E
authors.initials: E
authors.lastname: Obedia
mesh_terms: D018492:Dopamine Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D004358:Drug Therapy / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects* / Q000627:therapeutic use; D010820:Physicians; D011795:Surveys and Questionnaires
chemical_list: D018492:Dopamine Antagonists; D008787:Metoclopramide